273376-39-9

Usage

Uses

Used in Pharmaceutical Industry:
8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester, (3-endo)is used as a building block for the synthesis of various pharmaceuticals. Its unique structure and functional groups make it a valuable component in the development of novel drug molecules, particularly in the fields of medicinal chemistry and chemical biology.
Used as a Chiral Resolving Agent:
8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester, (3-endo)is used as a chiral resolving agent in asymmetric synthesis. Its ability to selectively interact with enantiomers makes it a valuable tool in the production of enantiomerically pure compounds, which are essential in the pharmaceutical industry for the development of drugs with improved efficacy and reduced side effects.
Used as a Ligand in Asymmetric Synthesis:
8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester, (3-endo)is also utilized as a ligand in asymmetric synthesis. Its unique structure and properties enable it to facilitate the selective formation of enantiomers, which is crucial in the synthesis of chiral compounds with specific biological activities.
Used in Agrochemical Industry:
8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester, (3-endo)is used as a building block in the synthesis of various agrochemicals. Its versatile chemical properties make it suitable for the development of novel pesticides, herbicides, and other agrochemicals with improved performance and reduced environmental impact.

Upstream product

• 1257512-65-4 C₈H₁₅NO 
• 24424-99-5 di-tert-butyl dicarbonate 
• 185099-67-6 N-Boc-nortropinone 
• 852460-98-1 [(3-endo)-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-3-yl]methanol 

Downstream Products

• 852435-93-9 (3-endo)-tert-butyl-3-({[(4-methylphenyl)sulfonyl]oxy}methyl)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 142892-37-3 ((endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl)methanol 
• 861133-95-1 1,1-dimethylethyl (3-endo)-[({[(2-bromo-5-methylphenyl)amino]arbonyl}oxy)methyl]-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1309766-23-1 C₂₄H₃₁N₃O₅S 
• 1309766-33-3 C₁₉H₂₃N₃O₃S 
• 1309766-26-4 C₂₄H₂₉N₃O₅S 
• 1309766-29-7 C₂₆H₃₁N₅O₃S 
• 1309766-24-2 C₂₄H₃₀FN₃O₅S 
• 850607-53-3 3-[(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl]-2,2-diphenylpropanenitrile 
• 852435-97-3 (3-endo)-3-[8-(5-hexen-1-yl)-8-azabicyclo[3.2.1]oct-3-yl]-2,2-diphenylpropanenitrile 
• 852461-01-9 (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8-(cyclohexylmethyl)-8-methyl-8-azoniabicyclo[3.2.1]octane bromide 
• 852460-99-2 Br^(1-)*C₂₉H₃₇N₂⁽¹⁺⁾ 

Relevant academic research and scientific papers

Functional Group Interconversion of Alkylidenemalononitriles to Primary Alcohols by a Cooperative Redox Operation

Functional group interconversions are essential chemical processes enabling synthesis. In this report, we describe a strategy to convert alkylidenemalononitriles into primary alcohols in one step. The reaction relies on a choreographed redox process invol

SUBSTITUTED BIARYL DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to Substituted Biaryl Derivatives, compositions comprising a Substituted Biaryl Derivative, and methods of using the Substituted Biaryl Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR119 in a patient.

MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS

Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.

M3 MUSCARINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS

Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.